ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

XNCR Xencor Inc

23.63
0.00 (0.00%)
시간외 단일가
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Xencor Inc XNCR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 23.63 09:00:00
개장가 저가 고가 종가 전일 종가
23.63
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/04/202421:01BWXencor Appoints Bart Cornelissen as Chief Financial Officer
12/03/202404:47EDGAR2Form 144 - Report of proposed sale of securities
12/03/202404:45EDGAR2Form 144 - Report of proposed sale of securities
12/03/202404:40EDGAR2Form 144 - Report of proposed sale of securities
12/03/202404:40EDGAR2Form 144 - Report of proposed sale of securities
08/03/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202404:39EDGAR2Form 144 - Report of proposed sale of securities
06/03/202422:32EDGAR2Form 8-K - Current report
06/03/202406:48EDGAR2Form 144 - Report of proposed sale of securities
06/03/202406:34EDGAR2Form 144 - Report of proposed sale of securities
06/03/202406:27EDGAR2Form 144 - Report of proposed sale of securities
29/02/202406:01BWXencor to Present at Upcoming Investor Conferences
28/02/202406:05EDGAR2Form 8-K - Current report
28/02/202406:01BWXencor Reports Fourth Quarter and Full Year 2023 Financial..
21/02/202406:31BWXencor to Host Webcast to Review Fourth Quarter and Full..
17/02/202407:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/02/202406:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202408:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202404:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202406:07EDGAR2Form 144 - Report of proposed sale of securities
04/01/202406:01BWXencor to Present at the 42nd Annual J.P. Morgan Healthcare..
02/01/202422:01BWDane Leone Joins Xencor as Senior Vice President, Corporate..
30/12/202306:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202305:28EDGAR2Form 144 - Report of proposed sale of securities
22/11/202306:01BWXencor to Present at the Piper Sandler 35th Annual..
16/11/202306:02EDGAR2Form 8-K - Current report
08/11/202306:04EDGAR2Form 8-K - Current report
08/11/202306:03EDGAR2Form 8-K - Current report
08/11/202306:01BWXencor Reports Third Quarter 2023 Financial Results
04/11/202301:01BWXencor Presents Preclinical Data from Multiple XmAb®..
01/11/202305:01BWXencor to Host Third Quarter 2023 Financial Results Webcast..
26/10/202321:11EDGAR2Form 8-K - Current report
26/10/202321:01BWXencor Announces Planned Retirement of Chief Financial..
27/09/202322:01BWXencor to Present Multiple Posters at the SITC Annual..
20/09/202305:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/09/202305:31EDGAR2Form 8-K - Current report
20/09/202305:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/09/202305:01BWXencor Appoints Barbara J. Klencke, M.D., to Board of..
04/08/202306:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:02EDGAR2Form 8-K - Current report
04/08/202305:01BWXencor Reports Second Quarter 2023 Financial Results
27/07/202321:01BWXencor to Host Second Quarter 2023 Financial Results Webcast..
03/07/202320:16EDGAR2Form 8-K - Current report
31/05/202307:01BWXencor Presents Clinical Results from Phase 1a Study of..
09/05/202305:01BWXencor Reports First Quarter 2023 Financial Results

최근 히스토리

Delayed Upgrade Clock